Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 94,572 shares at $60.40 ($5.9M) on 2021-11-01, disclosed to the SEC on 2021-11-02.
Open-market sale of $5.9M KYMR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.40 | 7,387 | $446K | 7.6% |
| 2 | $60.40 | 7,387 | $446K | 7.6% |
| 3 | $61.50 | 15,134 | $931K | 15.8% |
| 4 | $62.34 | 15,911 | $992K | 16.9% |
| 5 | $62.34 | 15,911 | $992K | 16.9% |
| 6 | $63.17 | 4,065 |
| $257K |
| 4.4% |
| 7 | $63.17 | 4,065 | $257K | 4.4% |
| 8 | $62.89 | 8,514 | $535K | 9.1% |
| 9 | $62.89 | 8,514 | $535K | 9.1% |
| 10 | $63.50 | 5,280 | $335K | 5.7% |
| 11 | $64.34 | 1,202 | $77K | 1.3% |
| 12 | $64.34 | 1,202 | $77K | 1.3% |
| Total | $62.19 avg | 94,572 | $5.9M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |